Association between allergic diseases and mental health conditions: an umbrella review.

IF 11.4 1区 医学 Q1 ALLERGY Journal of Allergy and Clinical Immunology Pub Date : 2024-11-07 DOI:10.1016/j.jaci.2024.10.030
Xianpeng Xu, Sha Li, Yingjie Chen, Xinxing Deng, Jiongke Li, Dajing Xiong, Hui Xie
{"title":"Association between allergic diseases and mental health conditions: an umbrella review.","authors":"Xianpeng Xu, Sha Li, Yingjie Chen, Xinxing Deng, Jiongke Li, Dajing Xiong, Hui Xie","doi":"10.1016/j.jaci.2024.10.030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The mental health conditions of allergic diseases has been investigated, but the consistency and magnitude of their effects are unclear. The aim of this umbrella review is to systematically evaluate the published evidence on allergic diseases and mental health conditions to establish a new hierarchy of evidence and identify gaps in this area of research.</p><p><strong>Methods: </strong>We systematically searched PubMed, Embase, Web of Science and the Cochrane Database of Systematic Reviews from database inception to April 30, 2024. We included systematic reviews that conducted meta-analyses that examined the association of allergic diseases and mental health conditions. We calculated summary effect estimates (odds ratio [OR]), 95% confidence intervals, I<sup>2</sup>statistic, 95% prediction interval, small study effects, and excess significance biases. We used AMSTAR 2 to appraise the methodological quality of the included studies.</p><p><strong>Results: </strong>We identified 21 eligible articles which yielded 37 associations (38,4405,029 total population) of allergic diseases and mental health conditions. The credibility of evidence was convincing (class I) for asthma and risk of attention deficit/hyperactivity disorder (ADHD) (OR 1.34, 1.24-1.44); and highly suggestive (class II) for allergic rhinitis and risk of tic disorders (OR 2.61, 1.90-3.57), allergic rhinitis and risk of sleep disorders (OR 2.17, 1.87-2.53), food allergy and risk of autism spectrum disorder (ASD) (OR 2.79, 2.08-3.75), atopic dermatitis and risk of depression (OR 1.60, 1.43-1.79), atopic dermatitis and risk of anxiety (OR 1.62 1.42-1.85), atopic dermatitis and risk of ADHD (OR 1.28, 1.18-1.40), atopic dermatitis and risk of suicidal ideation (OR 1.44, 1.25-1.65), asthma and risk of depression (OR 1.64, 1.50-1.78), asthma and risk of anxiety (OR 1.95, 1.68-2.26), asthma and risk of tic disorders (OR 1.90, 1.57-2.30), asthma and risk of suicidal ideation (OR 1.52, 1.37-1.70), and asthma and risk of suicide attempts (OR 1.60, 1.33-1.92).</p><p><strong>Conclusions: </strong>Allergic diseases are associated with increased risk of a range of mental health conditions, with the most convincing evidence that asthma. However, these associations do not imply causality, and there is large heterogeneity in these associations, which requires high-quality preliminary studies to identify causality and strength of evidence.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.4000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2024.10.030","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The mental health conditions of allergic diseases has been investigated, but the consistency and magnitude of their effects are unclear. The aim of this umbrella review is to systematically evaluate the published evidence on allergic diseases and mental health conditions to establish a new hierarchy of evidence and identify gaps in this area of research.

Methods: We systematically searched PubMed, Embase, Web of Science and the Cochrane Database of Systematic Reviews from database inception to April 30, 2024. We included systematic reviews that conducted meta-analyses that examined the association of allergic diseases and mental health conditions. We calculated summary effect estimates (odds ratio [OR]), 95% confidence intervals, I2statistic, 95% prediction interval, small study effects, and excess significance biases. We used AMSTAR 2 to appraise the methodological quality of the included studies.

Results: We identified 21 eligible articles which yielded 37 associations (38,4405,029 total population) of allergic diseases and mental health conditions. The credibility of evidence was convincing (class I) for asthma and risk of attention deficit/hyperactivity disorder (ADHD) (OR 1.34, 1.24-1.44); and highly suggestive (class II) for allergic rhinitis and risk of tic disorders (OR 2.61, 1.90-3.57), allergic rhinitis and risk of sleep disorders (OR 2.17, 1.87-2.53), food allergy and risk of autism spectrum disorder (ASD) (OR 2.79, 2.08-3.75), atopic dermatitis and risk of depression (OR 1.60, 1.43-1.79), atopic dermatitis and risk of anxiety (OR 1.62 1.42-1.85), atopic dermatitis and risk of ADHD (OR 1.28, 1.18-1.40), atopic dermatitis and risk of suicidal ideation (OR 1.44, 1.25-1.65), asthma and risk of depression (OR 1.64, 1.50-1.78), asthma and risk of anxiety (OR 1.95, 1.68-2.26), asthma and risk of tic disorders (OR 1.90, 1.57-2.30), asthma and risk of suicidal ideation (OR 1.52, 1.37-1.70), and asthma and risk of suicide attempts (OR 1.60, 1.33-1.92).

Conclusions: Allergic diseases are associated with increased risk of a range of mental health conditions, with the most convincing evidence that asthma. However, these associations do not imply causality, and there is large heterogeneity in these associations, which requires high-quality preliminary studies to identify causality and strength of evidence.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
过敏性疾病与精神健康状况之间的关系:综述。
背景:过敏性疾病对心理健康的影响已得到研究,但其影响的一致性和程度尚不明确。本综述旨在系统评估已发表的有关过敏性疾病和精神健康状况的证据,以建立新的证据等级体系,并找出该领域研究的空白点:我们系统地检索了 PubMed、Embase、Web of Science 和 Cochrane 系统性综述数据库(从数据库建立之初到 2024 年 4 月 30 日)。我们纳入了对过敏性疾病与精神健康状况的关联性进行荟萃分析的系统综述。我们计算了汇总效应估计值(几率比 [OR])、95% 置信区间、I2 统计量、95% 预测区间、小研究效应和过度显著性偏倚。我们使用 AMSTAR 2 评估了纳入研究的方法学质量:结果:我们确定了 21 篇符合条件的文章,其中 37 篇文章(总人数为 38 4405 029 人)涉及过敏性疾病和精神健康状况。哮喘与注意力缺陷/多动症(ADHD)风险的证据可信度令人信服(I级)(OR 1.34,1.24-1.44);过敏性鼻炎与抽搐症风险的证据可信度高度提示(II级)(OR 2.61,1.90-3.57)、过敏性鼻炎与睡眠障碍风险(OR 2.17,1.87-2.53)、食物过敏与自闭症谱系障碍(ASD)风险(OR 2.79,2.08-3.75)、特应性皮炎与抑郁症风险(OR 1.60,1.43-1.79)、特应性皮炎与焦虑风险(OR 1.62 1.42-1.85)、特应性皮炎与多动症风险(OR 1.28,1.18-1.40)、特应性皮炎与自杀倾向风险(OR 1.44,1.25-1.65)、哮喘与抑郁风险(OR 1.64,1.50-1.78)、哮喘与焦虑风险(OR 1.95,1.68-2.26)、哮喘与抽搐症风险(OR 1.90,1.57-2.30)、哮喘与自杀意念风险(OR 1.52,1.37-1.70)、哮喘与自杀未遂风险(OR 1.60,1.33-1.92):结论:过敏性疾病与一系列心理健康问题的风险增加有关,其中最有说服力的证据是哮喘。然而,这些关联并不意味着因果关系,而且这些关联存在很大的异质性,因此需要进行高质量的初步研究,以确定因果关系和证据的强度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
25.90
自引率
7.70%
发文量
1302
审稿时长
38 days
期刊介绍: The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.
期刊最新文献
An updated review of the use of omalizumab for the treatment of uncontrolled pediatric allergic asthma. Anti-IgE therapy in chronic rhinosinusitis with nasal polyps. COVID-19 in children: Evolving epidemiology, immunology, symptoms, diagnostics, treatment, post covid conditions, prevention strategies, and future directions. Making Sense of Adenosine Deaminase Variants and Their Clinical Implications. The importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1